Opioid REMS Requires Sponsors To Launch Prescriber Training CME Within 9 Months
This article was originally published in The Pink Sheet Daily
Executive Summary
By the third year of continuing medical education efforts, FDA expects 60% of those who wrote a prescription for a long-acting/extended-release opioid in 2011 to receive training.